Actively Recruiting
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
Led by Lovisenberg Diakonale Hospital · Updated on 2023-11-07
130
Participants Needed
2
Research Sites
515 weeks
Total Duration
On this page
Sponsors
L
Lovisenberg Diakonale Hospital
Lead Sponsor
H
Haukeland University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
CONDITIONS
Official Title
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eligible for primary reverse shoulder arthroplasty due to osteoarthritis, massive rotator cuff tear, failed rotator cuff repair, or post-instability osteoarthritis
- Able to read or write Norwegian
You will not qualify if you...
- Severe osteoporosis
- Osteonecrosis of the humeral head
- Dementia
- Poor deltoid function
- Revision surgery
- ASA IV status
- Suspected chronic infection
- Acute fracture
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Sykehuset Telemark HF
Skien, Telemark, Norway, 3710
Not Yet Recruiting
2
Lovisenberg Diaconal Hospital
Oslo, Norway, 0456
Actively Recruiting
Research Team
K
Kjersti Kaul Jenssen, PhD
CONTACT
H
Hanne Fuglø, MPTh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here